Zenas BioPharma, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Zenas BioPharma, Inc. (ZBIO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 8.68 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- 2026-06-30: Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month 8.68M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month |
|---|---|
| 2026-06-30 | 8.68M shares 10-Q · filed 2026-08-13 |